Millions of Americans are using GLP-1s. But so far, there has been comparatively less research on what happens when users ...

People taking an obesity drug typically regain weight, a new review finds, often even quicker than people who lose weight ...

When people stop taking the new generation of weight-loss drugs, they pile back on the kilos four times faster than they ...

Those who stop taking weight loss medication are likely to regain all the weight lost in less than two years, a new study ...

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review ...

“With world-class investors and a team that has repeatedly brought metabolic medicines from concept to commercialization, Alveus is well positioned to lead the next wave of innovation in obesity ...

The cost, the shortages, and even the side effects have led to older people who start Ozempic, Wegovy, and similar drugs to stop them after a few months.

A new review of popular weight-loss drugs such as Ozempic and Zepbound has found that users regained weight within two years after ending the medication, raising concerns among experts and public ...

Labor is weighing up advice to subsidise weight-loss drugs to treat obese people with heart disease, but doctors say more ...

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.